American Century Companies’s Bicara Therapeutics BCAX Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAX
SL
RTM
VCM
ACM
American Century Companies's BCAX Position: Q2 2026 in Review
American Century Companies increased its Bicara Therapeutics (BCAX) stake by 60% in Q2 2026, buying an estimated $695K and bringing the position to 82,716 shares worth $2.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2138.
American Century Companies first reported a position in BCAX in Q2 2025 and has held it in 5 quarters since. 112 funds tracked by Wall St. Rank hold BCAX as of Q2 2026.
- American Century Companies held 82,716 shares of Bicara Therapeutics worth $2.46M as of Q2 2026.
- American Century Companies bought 31,163 Bicara Therapeutics shares in Q2 2026, an estimated $695K.
- Bicara Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2138 holding.
- American Century Companies first reported a position in Bicara Therapeutics in Q2 2025 and has held it in 5 quarters since.
- 112 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.